Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses

Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Etto...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Cardiovascular interventions 2011-11, Vol.4 (11), p.1228-1234
Hauptverfasser:	Bedogni, Francesco, MD, Laudisa, Maria Luisa, MD, PhD, Pizzocri, Samuele, MD, Tamburino, Corrado, MD, Ussia, Gian Paolo, MD, Petronio, Anna Sonia, MD, Napodano, Massimo, MD, Ramondo, Angelo, MD, Presbitero, Patrizia, MD, Ettori, Federica, MD, Santoro, Gennaro, MD, Klugman, Silvio, MD, De Marco, Federico, MD, Brambilla, Nedy, MD, Testa, Luca, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - physiopathology Aortic Valve Stenosis - surgery Bioprosthesis Cardiac Catheterization - adverse effects Cardiac Catheterization - instrumentation Cardiac Catheterization - mortality Cardiovascular CoreValve Revalving System failed surgical aortic bioprosthesis Feasibility Studies Female Heart Valve Prosthesis Heart Valve Prosthesis Implantation - adverse effects Heart Valve Prosthesis Implantation - instrumentation Heart Valve Prosthesis Implantation - methods Heart Valve Prosthesis Implantation - mortality Humans Italy Male Prosthesis Design Prosthesis Failure Risk Assessment Risk Factors Severity of Illness Index TAVI Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses Francesco Bedogni, Maria Luisa Laudisa, Samuele Pizzocri, Corrado Tamburino, Gian Paolo Ussia, Anna Sonia Petronio, Massimo Napodano, Angelo Ramondo, Patrizia Presbitero, Federica Ettori, Gennaro Santoro, Silvio Klugman, Federico De Marco, Nedy Brambilla, Luca Testa CoreValve Revalving System (Medtronic, Minneapolis, Minnesota) implantation could be a valid option for patients with a failed aortic bioprosthesis deemed at prohibitive risk for surgical redo. In this multicenter consecutive cohort of 25 patients, the CoreValve Revalving System was feasible and effective regardless of the prevalent cause of failure (regurgitation or stenosis), with excellent procedural success and a considerable 6-month survival rate. These results can significantly affect the treatment of such a high-risk population.
ISSN:	1936-8798 1876-7605
DOI:	10.1016/j.jcin.2011.10.002